Skip to content
10-Q

Quarterly Report

Viemed Healthcare, Inc. VMD

0001729149-25-000096

← back to feed
Filed
May 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 29, 2025 39.52M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $3.53M
Long Term Debt Q1 2025 · Dec 31, 2024 $3.59M
Short Term Debt Q1 2025 · Mar 31, 2025 $390K
Short Term Debt Q1 2025 · Dec 31, 2024 $409K
Cash And Equivalents Q1 2025 · Mar 31, 2025 $10.16M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $17.54M
Stockholders Equity Q1 2025 · Mar 31, 2025 $134.76M
Stockholders Equity Q1 2025 · Dec 31, 2024 $131.39M
Current Liabilities Q1 2025 · Mar 31, 2025 $35.49M
Current Liabilities Q1 2025 · Dec 31, 2024 $37.33M
Total Liabilities Q1 2025 · Mar 31, 2025 $41.33M
Total Liabilities Q1 2025 · Dec 31, 2024 $43.77M
Current Assets Q1 2025 · Mar 31, 2025 $49.12M
Current Assets Q1 2025 · Dec 31, 2024 $52.88M
Total Assets Q1 2025 · Mar 31, 2025 $178.08M
Total Assets Q1 2025 · Dec 31, 2024 $177.07M
Shares Diluted Q1 2025 · Mar 31, 2024 40.58M sh
Capex Q1 2025 · Mar 31, 2024 $6.01M
Operating Cash Flow Q1 2025 · Mar 31, 2024 $1.18M
Eps Diluted Q1 2025 · Mar 31, 2024 $0.04
Eps Basic Q1 2025 · Mar 31, 2024 $0.04
Sga Expense Q1 2025 · Mar 31, 2024 $24.81M
Rd Expense Q1 2025 · Mar 31, 2024 $750K
Net Income Q1 2025 · Mar 31, 2024 $1.6M
Operating Income Q1 2025 · Mar 31, 2024 $2.2M
Gross Profit Q1 2025 · Mar 31, 2024 $29.8M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $20.79M
Revenue Q1 2025 · Mar 31, 2024 $50.59M